ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    nct00752206
Previous Study | Return to List | Next Study

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00752206
Recruitment Status : Active, not recruiting
First Posted : September 15, 2008
Last Update Posted : October 11, 2017
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Sarcoma Alliance for Research through Collaboration

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2017
  Estimated Study Completion Date : December 2017